Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7C6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,168
Award facts
- Contract value 100% obligated
- $31,168.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,168.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on December 23, 2025, with a completion date of December 24, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. The contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated capability to meet federal procurement requirements through its extensive portfolio of competitively awarded delivery orders with DLA and has been selected as one of multiple prime vendors under the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative. This specific delivery order reflects the company's role as a key supplier within the military healthcare supply chain for specialty pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FV7C6?
SPE2DR26FV7C6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FV7C6 worth?
The government has obligated $31,168 on SPE2DR26FV7C6.
Is contract SPE2DR26FV7C6 an order under another contract?
Yes. SPE2DR26FV7C6 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7C6 competed?
The extent of competition for SPE2DR26FV7C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award